Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 8, 2012Clinical EndocrinologyOpen Access

Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

YWYu Cho WooUniversity of Hong KongAXAimin XuZhejiang Wanli UniversityYWYu WangQingdao University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Woo et al. (2012) studied this question.

synapsesocial.com/papers/6a7722f5d8eb58afc2bda766https://doi.org/10.1111/cen.12095
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dynamic Change of Serum FGF21 Levels in Response to Glucose Challenge in Human2012 · 59 citations
  2. 2Paradoxical Regulation of Human FGF21 by Both Fasting and Feeding Signals: Is FGF21 a Nutritional Adaptation Factor?2011 · 99 citations
  3. 3Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21) in Vivo2011 · 235 citations
  4. 4Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor‐21 in patients with type 2 diabetes and obesity2008 · 283 citations
  5. 5Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity2009 · 298 citations